Male fertility preservation in DSD, XXY, pre-gonadotoxic treatments – update, methods, ethical issues, current outcomes, future directions

Publication date: Available online 23 January 2019Source: Best Practice & Research Clinical Endocrinology & MetabolismAuthor(s): Maria Grazia Giudice, Federico Del Vento, Christine WynsAbstractThis paper aims at reviewing the fertility preservation strategies that could be considered in several conditions at risk of spermatogonial depletion such as 46,XY disorders of sexual development, Klinefelter syndrome and after gonadotoxic treatment in males highlighting current knowledge on diseases and processes involved in infertility as well as future directions along with their specific ethical issues.While sperm cryopreservation after puberty is the only validated technique for fertility preservation, for prepubertal boys facing gonadotoxic therapies or at risk of testicular tissue degeneration where testicular sperm is not present, cryopreservation of spermatogonial cells may be an option to ensure future parenthood. Promising results with transplantation and in vitro maturation of spermatogonial cells were achieved in animals but so far none of the techniques was applied in humans.
Source: Best Practice and Research Clinical Endocrinology and Metabolism - Category: Endocrinology Source Type: research